Drugs causing severe ocular surface involvements in Japanese patients with Stevens–Johnson syndrome/toxic epidermal necrolysis

  • Kaniwa Nahoko
    Division of Medicinal Safety Science, National Institute of Health Sciences
  • Ueta Mayumi
    Department of Ophthalmology, Kyoto Prefectural University of Medicine
  • Nakamura Ryosuke
    Division of Medicinal Safety Science, National Institute of Health Sciences
  • Okamoto-Uchida Yoshimi
    Division of Medicinal Safety Science, National Institute of Health Sciences
  • Sugiyama Emiko
    Division of Medicinal Safety Science, National Institute of Health Sciences
  • Maekawa Keiko
    Division of Medicinal Safety Science, National Institute of Health Sciences
  • Takahashi Yukitoshi
    Shizuoka Institute of Epilepsy and Neurological Disorders
  • Furuya Hirokazu
    Department of Neurology, Kochi Medical School
  • Yagami Akiko
    Department of Dermatology, School of Medicine, Fujita Health University
  • Matsukura Setsuko
    Department of Environmental Immuno-Dermatology, Graduate School of Medicine, Yokohama City University
  • Ikezawa Zenro
    Department of Environmental Immuno-Dermatology, Graduate School of Medicine, Yokohama City University
  • Matsunaga Kayoko
    Department of Dermatology, School of Medicine, Fujita Health University
  • Sotozono Chie
    Department of Ophthalmology, Kyoto Prefectural University of Medicine
  • Aihara Michiko
    Department of Environmental Immuno-Dermatology, Graduate School of Medicine, Yokohama City University
  • Kinoshita Shigeru
    Department of Ophthalmology, Kyoto Prefectural University of Medicine
  • Saito Yoshiro
    Division of Medicinal Safety Science, National Institute of Health Sciences

書誌事項

タイトル別名
  • Drugs causing severe ocular surface involvements in Japanese patients with StevenseJohnson syndrome/toxic epidermal necrolysis

この論文をさがす

収録刊行物

被引用文献 (4)*注記

もっと見る

参考文献 (9)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ